×

本司产品仅用于科研,不用于临床诊断和治疗

全国免费热线:400-999-2100

您身边的细胞培养专家!

所有分类
  • 所有分类
  • 细胞系
  • 原代细胞
  • 血清
  • 细胞培养基
  • 辅助试剂
  • 细胞凋亡检测试剂盒
  • 细胞房除菌产品
热搜: 胎牛血清 VERO RAW264.7 成纤维细胞 间充质干细胞 上皮细胞

忘记密码

个人邮箱:
验证码: captcha

账号激活

个人邮箱:
×
当前位置:首页 >> 产品中心 >> 细胞资源库 >> 细胞系 >> 

产品中心Cell Resources

联系我们CONTACT US

  • U266 [U266B1] (人多发性骨髓瘤细胞) (STR鉴定正确)
  • U266 [U266B1] (人多发性骨髓瘤细胞) (STR鉴定正确)
  • U266 [U266B1] (人多发性骨髓瘤细胞) (STR鉴定正确)
  • U266 [U266B1] (人多发性骨髓瘤细胞) (STR鉴定正确)
  • U266 [U266B1] (人多发性骨髓瘤细胞) (STR鉴定正确)
  • U266 [U266B1] (人多发性骨髓瘤细胞) (STR鉴定正确)
  • U266 [U266B1] (人多发性骨髓瘤细胞) (STR鉴定正确)
  • U266 [U266B1] (人多发性骨髓瘤细胞) (STR鉴定正确)

U266 [U266B1] (人多发性骨髓瘤细胞) (STR鉴定正确)

货号:CL-0510

规格:1×10⁶cells/T25培养瓶

价格: ¥2200

生长培养基:RPMI-164010% FBS1% P/S

数量: - +

  • U266 [U266B1] (人多发性骨髓瘤细胞) (STR鉴定正确)
  • U266 [U266B1] (人多发性骨髓瘤细胞) (STR鉴定正确)
  • U266 [U266B1] (人多发性骨髓瘤细胞) (STR鉴定正确)
  • U266 [U266B1] (人多发性骨髓瘤细胞) (STR鉴定正确)
  • U266 [U266B1] (人多发性骨髓瘤细胞) (STR鉴定正确)
  • U266 [U266B1] (人多发性骨髓瘤细胞) (STR鉴定正确)
  • U266 [U266B1] (人多发性骨髓瘤细胞) (STR鉴定正确)
  • U266 [U266B1] (人多发性骨髓瘤细胞) (STR鉴定正确)

推荐搭配

套餐1:

U266 [U266B1] (人多发性骨髓瘤细胞) (STR鉴定正确) ¥2200
U266 [U266B1]细胞专用培养基
  • ¥350
  • ¥450

现单独购买该产品也可享受限时优惠价!

细胞培养最优解!

套餐组合价:¥2550¥2650

加入购物车

搭配套餐已成功加入购物车!

产品概述
产品信息
名称 U266 [U266B1] (人多发性骨髓瘤细胞) (STR鉴定正确)
种属
生长特性 悬浮细胞
细胞形态 淋巴母细胞样
冻存条件 冻存液:55% 基础培养基+40%FBS+5%DMSO 温度:液氮
培养方案A(默认)
生长培养基:
培养条件:
气相:空气,95%;CO2,5%, 温度:37℃
推荐传代比例 1:2-1:4
推荐换液频率 2-3次/周
注意事项 该细胞为悬浮细胞,请注意离心收集细胞悬液;请勿直接倒掉细胞培养液。
参考资料(来源文献)
年龄(性别) 男性;53岁
组织来源 骨髓瘤;B淋巴细胞
细胞类型 肿瘤细胞
肿瘤类型 骨髓瘤细胞
STR鉴定
  • STR位点信息
    Amelogenin X,Y
    CSF1PO 12,13
    D2S1338 20,23
    D3S1358 17
    D5S818 11,12
    D7S820 11,12
    D8S1179 13
    D13S317 12
    D16S539 10
    D18S51 12,14
    D19S433 13,15
    D21S11 28,29
    FGA 18
    PentaD 10,13
    PentaE 10,11
    TH01 5,7
    TPOX 8
    vWA 17
    D6S1043 11,17
    D12S391 18
    D2S441 10,11
  • STR鉴定图
参考文献
文献列表
  • Ethanol Extract of Eclipta prostrata induces Multiple Myeloma Ferroptosis via Keap1/Nrf2/HO-1 Axis (2024-02-01)

    作者:Wenxia Li:1.Hangzhou Innovation Institute, Beihang University, Hangzhou, Zhejiang, PR China; Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, PR China. ; Xuejiao Yin:1.Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, PR China. ; Hangjie Fu:1.School of Public Health, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, PR China; College of Life Science, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, PR China. ; Jinyuan Liu:1.College of Life Science, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, PR China. ; Zhiwei Weng:1.College of Life Science, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, PR China. ; Qingqing Mao:1.College of Life Science, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, PR China. ; Lijian Zhu:1.College of Life Science, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, PR China.

    期刊:Ethanol Extract of Eclipta prostrata induces Multiple Myeloma Ferroptosis via Keap1/Nrf2/HO-1 Axis

    DOI:10.1016/j.phymed.2024.155401

    影响因子 :7.9

    引用产品: RPMI 8226 细胞 ,  U266 [U266B1] 细胞

  • Bispecific NK-cell engager targeting BCMA elicits stronger antitumor effects and produces less proinflammatory cytokines than T-cell engager (2023-04-11)

    作者:Xinghui Xiao:1.Hefei National Research Center for Physical Sciences at Microscale, The CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China. ; 2.Institute of Immunology, University of Science and Technology of China, Hefei, China. ; Ying Cheng:1.Hefei National Research Center for Physical Sciences at Microscale, The CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China. ; 2.Institute of Immunology, University of Science and Technology of China, Hefei, China. ; Xiaodong Zheng:1.Hefei National Research Center for Physical Sciences at Microscale, The CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Techno

    期刊:Bispecific NK-cell engager targeting BCMA elicits stronger antitumor effects and produces less proinflammatory cytokines than T-cell engager

    DOI:10.3389/fimmu.2023.1113303

    影响因子 :7.3

    引用产品: U266 [U266B1] 细胞

  • LGR4 promotes tumorigenesis by activating TGF-β1/Smad signaling pathway in multiple myeloma (2023-07-18)

    作者:Zhigang Yi:1.Department of Hematology, Lanzhou University Second Hospital, Lanzhou, China; Department of Pediatric Orthopedics and Pediatrics, Lanzhou University Second Hospital, Lanzhou, China. ; Tao Ma:1.Department of Hematology, Lanzhou University Second Hospital, Lanzhou, China; Department of Hematology, The Affiliated Hospital of Southwest Medical University, Luzhou, China. ; Jia Liu:1.Department of Hematology, Lanzhou University Second Hospital, Lanzhou, China. ; Wenting Tie:1.Department of Hematology, Lanzhou University Second Hospital, Lanzhou, China. ; Yanhong Li:1.Department of Hematology, Lanzhou University Second Hospital, Lanzhou, China. ; Jun Bai:1.Department of Hematology, Lanzhou University Second Hospital, Lanzhou, China. ; Lijuan Li:1.Department of Hematology, Lanzhou University Second Hospital, Lanzhou, China. Electronic address: doctorjuan@sina.com. ; Liansheng Zhang:1.Department of Hematology, Lanzhou University Second Hospital, Lanzhou, China. Electronic ad

    期刊:LGR4 promotes tumorigenesis by activating TGF-β1/Smad signaling pathway in multiple myeloma

    DOI:10.1016/j.cellsig.2023.110814

    影响因子 :4.8

    引用产品: RPMI 8226 细胞 ,  AMO-1 细胞 ,  U266 [U266B1] 细胞

  • LAMP5 may promote MM progression by activating p38 (2023-03-22)

    作者:Yan Chen:1.Department of Hematology, The Affiliated Hospital of Southwest Medical University, Luzhou, China. ; Tao Ma:1.Department of Hematology, The Affiliated Hospital of Southwest Medical University, Luzhou, China. ;

    期刊:LAMP5 may promote MM progression by activating p38

    DOI:10.3389/pore.2023.1611083

    影响因子 :2.8

    引用产品: RPMI 8226 细胞 ,  U266 [U266B1] 细胞 ,  NCI-H929 细胞 ,  AMO-1 细胞

  • Hsa_Circ_0134426 Attenuates the Malignant Biological Behaviors of Multiple Myeloma by Suppressing miR-146b-3p to Upregulate NDNF (2022-12-02)

    作者:Menglan Li:1.Department of Hematology, Taikang Tongji (Wuhan)Hospital, No. 322, Sixin North Road, Hanyang District, Wuhan, 430050, Hubei, China. ; Jingyuan Li:1.Department of Hematology, Taikang Tongji (Wuhan)Hospital, No. 322, Sixin North Road, Hanyang District, Wuhan, 430050, Hubei, China. ; Yanyan Song:1.Department of Hematology, Taikang Tongji (Wuhan)Hospital, No. 322, Sixin North Road, Hanyang District, Wuhan, 430050, Hubei, China. yanyansong3@163.com. ;

    期刊:Hsa_Circ_0134426 Attenuates the Malignant Biological Behaviors of Multiple Myeloma by Suppressing miR-146b-3p to Upregulate NDNF

    DOI:10.1007/s12033-022-00618-6

    影响因子 :2.9

    引用产品: NCI-H929 细胞 ,  RPMI 8226 细胞 ,  U266 [U266B1] 细胞 ,  Normal Plasma Cells ,  RPMI-1640 培养基 ,  特级胎牛血清

  • Circ_SEC61A1 contributes to the progression of multiple myeloma cells via regulating miR-660-5p/CDK6 axis (2012-01-20)

    作者:Zimian Luo:1.Department of Hematology, Central Hospital of XiangTan, China. ; Yafei Yin:1.Department of Hematology, Central Hospital of XiangTan, China. ; Xiaojun Tan:1.Fertility & Genetic Center, Central Hospital of XiangTan, China. ; Kang Liu:1.Department of Hematology, Central Hospital of XiangTan, China. ; Zhi Chao:1.Department of Hematology, Central Hospital of XiangTan, China. ; Hong Xia:1.Epartment of Orthopedics, Central Hospital of XiangTan, China. Electronic address: Sunlight2235@126.com. ;

    期刊:Circ_SEC61A1 contributes to the progression of multiple myeloma cells via regulating miR-660-5p/CDK6 axis

    DOI:10.1016/j.leukres.2021.106774

    影响因子 :2.7

    引用产品: RPMI 8226 细胞 ,  U266 [U266B1] 细胞 ,  RPMI-1640 培养基 ,  青霉素-链霉素溶液 (双抗),100× ,  特级胎牛血清

  • Expression of STOML2 promotes proliferation and glycolysis of multiple myeloma cells via upregulating PAI-1 (2011-01-20)

    作者:Hongxia Zhang:1.Department of Hematology, First Affiliated Hospital, School of Medicine, Shihezi University, Shihezi City, 832008, Xinjiang Uygur Autonomous Region, China. ; Guangsheng Wu:1.Department of Hematology, First Affiliated Hospital, School of Medicine, Shihezi University, Shihezi City, 832008, Xinjiang Uygur Autonomous Region, China. ; Junjian Feng:1.Department of Intensive Care Unit, Luzhou People's Hospital, Luzhou City, 646000, Sichuan Province, China. ; Xiaohong Lu:1.Department of Hematology, Luzhou People's Hospital, Luzhou City, 646000, Sichuan Province, China. ; Ping Liu:1.Department of Pathology, Luzhou People's Hospital, Section 2 of JiuGu Avenue, Jiangyang District, Luzhou City, 646000, Sichuan Province, China. liuping_0901@163.com. ;

    期刊:Expression of STOML2 promotes proliferation and glycolysis of multiple myeloma cells via upregulating PAI-1

    DOI:10.1186/s13018-021-02819-2

    影响因子 :2.6

    引用产品: RPMI 8226 细胞 ,  NCI-H929 细胞 ,  U266 [U266B1] 细胞 ,  RPMI-1640 培养基

  • Lnc NEAT1/miR-29b-3p/Sp1 form a positive feedback loop and modulate bortezomib resistance in human multiple myeloma cells (2011-00-20)

    作者:Feifei Che:1.Department of Hematology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital, Chengdu, 610072, Sichuan, China. Electronic address: Chefeifei2@126.com. ; Xuemei Ye:1.Department of Hematology, Dongli Medical District of Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital, Chengdu, 610051, Sichuan, China. ; Yu Wang:1.Department of Hematology, Dongli Medical District of Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital, Chengdu, 610051, Sichuan, China. ; Shuyue Ma:1.Department of Hematology, Dongli Medical District of Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Ch

    期刊:Lnc NEAT1/miR-29b-3p/Sp1 form a positive feedback loop and modulate bortezomib resistance in human multiple myeloma cells

    DOI:10.1016/j.ejphar.2020.173752

    影响因子 :5.0

    引用产品: RPMI 8226 细胞 ,  U266 [U266B1] 细胞

  • 点击展开收起列表
FAQs

Q:{{item.question}}

A:

暂无数据
产品资料
注:百度浏览器无法支持扫一扫功能,请输入识别码,获取相应产品资料

识别码示意图

确定
邱国娜/胡文君

邱国娜/胡文君

【 上海 】

何帆

何帆

【 陕西、甘肃、宁夏、青海、新疆 】

 熊经理

熊经理

【 海南 】

朱莎莉

朱莎莉

【 湖北 】

刘本佳

刘本佳

【江苏(除南京外)】

章臣雄

章臣雄

【 广州 】

杜焱炜

杜焱炜

【 四川、云南、西藏 】

田博浩

田博浩

【 重庆、贵州 】

石文平

石文平

【 北京、辽宁 】

胡文君

胡文君

【江西】

李荣枫

李荣枫

【 天津、河北、内蒙古、山西 】

陈雨兰

陈雨兰

【 山东 】

尹国文

尹国文

【浙江】

唐小花

唐小花

【 吉林、黑龙江 】

付帅

付帅

【 安徽 】

朱俊宇

朱俊宇

【 河南、广西 】

李庆祖

李庆祖

【 湖南 】

熊志亮

熊志亮

【 深圳 】

梅文强

梅文强

【福建】

林钊光

林钊光

【南京】

微信扫一扫咨询

微信扫一扫咨询

在线客服
关闭
在线咨询

关注微信公众号